1.   Celgene is seeking approval of its thalidomide drug, Synovir, for treatment of erethyma nodosum leprosum, or ENL.

2.   Celgene developed its thalidomide drug to treat a skin condition called erythema nodosum leprosum, or ENL.

3.   Companies including EntreMed and Bristol-Myers Squibb Co. are also working on thalidomide drugs for a range of uses from Lupus to graft-versus-host disease.

4.   Companies including EntreMed an Bristol-Myers Squibb Co. are also working on thalidomide drugs for a range of uses from Lupus to graft-versus-host disease.

5.   Companies including EntreMed and Bristol-Myers are working on thalidomide drugs for a range of uses from Lupus to graft-versus-host disease.

6.   EntreMed Inc. and Bristol-Myers Squibb Co. are among other companies working on their own thalidomide drugs.

7.   Entremed Inc. and Bristol-Myers Squibb Inc. are among other companies working on their own thalidomide drugs.

8.   EntreMed and Bristol-Myers Squibb are working on their own thalidomide drugs for uses such as treatment of Lupus and graft-versus-host disease.

9.   Its new family of thalidomide drugs will be called Selcid.

10.   Rockville, Maryland-based EntreMed is developing a thalidomide drug for use in healing the excruciatingly painful mouth ulcers that often occur in AIDS patients.